| Dena Lynne Rose, PT | |
|
109 Vierse Dr, Farmington, MO 63640-1323 | |
| (573) 756-2937 | |
| (573) 756-2939 |
| Full Name | Dena Lynne Rose |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 34 Years |
| Location | 109 Vierse Dr, Farmington, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205947058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 02200 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Axes Physical Therapy Llc | 3375840028 | 76 |
News Archive
ProAssurance Corporation today announced the completion of its previously announced acquisition of American Physicians Service Group, Inc.. APS shareholders overwhelmingly approved the transaction at a special meeting on November 29, 2010.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of Merkel cell carcinoma.
In 2015, the International Agency for Research on Cancer (IARC) published a series of monographs on the evaluation of various carcinogenic risks. In a monograph on air pollution, the organization pointed out the difficulty of assessing the effects of pollution on multiple types of cancers, given their different etiologies, risk factors and variability in the composition of air pollutants in space and time. However, the IARC identified certain key components of air pollution, including particulates.
Italian research shows that long-term imatinib discontinuation is feasible outside of a clinical trial setting for patients with chronic myeloid leukaemia who achieve stable undetectable molecular disease with front-line treatment.
› Verified 5 days ago
| Provider Name | Axes Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1003280421 PECOS PAC ID: 3375840028 Enrollment ID: O20160324001215 |
News Archive
ProAssurance Corporation today announced the completion of its previously announced acquisition of American Physicians Service Group, Inc.. APS shareholders overwhelmingly approved the transaction at a special meeting on November 29, 2010.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of Merkel cell carcinoma.
In 2015, the International Agency for Research on Cancer (IARC) published a series of monographs on the evaluation of various carcinogenic risks. In a monograph on air pollution, the organization pointed out the difficulty of assessing the effects of pollution on multiple types of cancers, given their different etiologies, risk factors and variability in the composition of air pollutants in space and time. However, the IARC identified certain key components of air pollution, including particulates.
Italian research shows that long-term imatinib discontinuation is feasible outside of a clinical trial setting for patients with chronic myeloid leukaemia who achieve stable undetectable molecular disease with front-line treatment.
› Verified 5 days ago
| Provider Name | Axes Physical Therapy I, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1679032700 PECOS PAC ID: 9335481688 Enrollment ID: O20190507001063 |
News Archive
ProAssurance Corporation today announced the completion of its previously announced acquisition of American Physicians Service Group, Inc.. APS shareholders overwhelmingly approved the transaction at a special meeting on November 29, 2010.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of Merkel cell carcinoma.
In 2015, the International Agency for Research on Cancer (IARC) published a series of monographs on the evaluation of various carcinogenic risks. In a monograph on air pollution, the organization pointed out the difficulty of assessing the effects of pollution on multiple types of cancers, given their different etiologies, risk factors and variability in the composition of air pollutants in space and time. However, the IARC identified certain key components of air pollution, including particulates.
Italian research shows that long-term imatinib discontinuation is feasible outside of a clinical trial setting for patients with chronic myeloid leukaemia who achieve stable undetectable molecular disease with front-line treatment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dena Lynne Rose, PT 109 Vierse Dr, Farmington, MO 63640-1323 Ph: (573) 756-7848 | Dena Lynne Rose, PT 109 Vierse Dr, Farmington, MO 63640-1323 Ph: (573) 756-2937 |
News Archive
ProAssurance Corporation today announced the completion of its previously announced acquisition of American Physicians Service Group, Inc.. APS shareholders overwhelmingly approved the transaction at a special meeting on November 29, 2010.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of Merkel cell carcinoma.
In 2015, the International Agency for Research on Cancer (IARC) published a series of monographs on the evaluation of various carcinogenic risks. In a monograph on air pollution, the organization pointed out the difficulty of assessing the effects of pollution on multiple types of cancers, given their different etiologies, risk factors and variability in the composition of air pollutants in space and time. However, the IARC identified certain key components of air pollution, including particulates.
Italian research shows that long-term imatinib discontinuation is feasible outside of a clinical trial setting for patients with chronic myeloid leukaemia who achieve stable undetectable molecular disease with front-line treatment.
› Verified 5 days ago
Cliff Michael Prather, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 Maple Valley Dr, Farmington, MO 63640 Phone: 573-260-1678 | |
Dr. Bradley Christian Morr, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 109 Vierse Dr, Farmington, MO 63640 Phone: 573-756-2937 | |
Clinton Dale Rice, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 602 Maple Valley Dr, Farmington, MO 63640 Phone: 573-756-2999 | |
Brandi Nicole Schwartz, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1355 Maple Street, Farmington, MO 63640 Phone: 573-756-9900 Fax: 573-756-9988 | |
Crystal Rippee, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1355 Maple St, Farmington, MO 63640 Phone: 573-756-9900 Fax: 573-756-9988 | |
Athletico Ltd Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1355 Maple St, Farmington, MO 63640 Phone: 573-756-9900 Fax: 573-756-9988 |